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Background: Understanding the underlying causes of nicotine addiction will require a multidisciplinary approach
examining the key molecular, cellular and neuronal circuit functional changes that drive escalating levels of nicotine
self-administration. In this study, we examined whether mice pretreated with chronic nicotine, at a dosing regimen that
results in maximal nicotinic acetylcholine receptor (nAChR) upregulation, would display evidence of nicotine-dependent
behaviour during nicotine self-administration.
Results: We investigated oral self-administration of nicotine using a two-bottle choice paradigm in which one bottle
contained the vehicle (saccharine-sweetened water), while the other contained nicotine (200 μg/ml) in vehicle. Knock-in
mice with YFP-tagged α4 nAChR subunits (α4YFP) were implanted with osmotic pumps delivering either nicotine
(2 mg/kg/hr) or saline for 10 days. After 10 days of pretreatment, mice were exposed to the nicotine self-administration
paradigm, consisting of four days of choice followed by three days of nicotine abstinence repeated for five weeks. Mice
pre-exposed to nicotine had upregulated α4YFP nAChR subunits in the hippocampal medial perforant path and on
ventral tegmental area GABAergic neurons as compared to chronic saline mice. Compared to control saline-pretreated
mice, in a two bottle-choice experiment, nicotine-primed mice ingested a significantly larger daily dose of nicotine and
also exhibited post-abstinence binge drinking of nicotine.
Conclusions: Chronic forced pre-exposure of nicotine is sufficient to induce elevated oral nicotine intake and supports
the postulate that nAChR upregulation may be a key factor influencing nicotine self-administration.Background
Tobacco smoking inflicts a heavy toll on the world’s popu-
lation, cutting the life expectancy of smokers by up to ten
years [1] and nicotine dependence is the primary reason
for the continued use of tobacco even in the face of com-
promising one’s health. The behaviours of drug seeking,
reinforcement, tolerance and withdrawal associated with
nicotine addiction are mediated at the molecular level by
nicotinic acetylcholine receptors (nAChRs) [2-5].
Nicotine targets many areas in the brain due to the fact
that nAChRs have a widespread distribution throughout
the CNS [6,7]. There are a total of 12 neuronal subunits
in vertebrates (α2-10, β2-4) assembling into a variety of
nAChR subtypes, of which the major subtype in the brain
is the heteropentameric α4β2* nAChR (* denotes that the* Correspondence: raad@uvic.ca
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[8]. Nicotine’s impact on various aspects of nicotine ad-
dictive behavior, including drug seeking, reinforcement,
tolerance and withdrawal is likely due to nicotine targeting
nAChRs localized on different neuronal circuits in the
brain. The ventral tegmental area is a key neural substrate
located in the ventral midbrain which mediates reward, re-
ward prediction or even aversion [9-11] and is therefore a
prime target for drugs of abuse such as nicotine [4,12-14].
Nicotine provides positive reinforcement by activating
α4-containing (α4*) and β2-containing (β2*) nAChRs in
the ventral tegmental area [3-5,14,15] and chronic ad-
ministration of nicotine upregulates high-affinity α4β2
nAChR expression in mice [6,7,16] and rats [17], altering
the molecular circuitry that governs reward. Importantly,
the brains of human smokers also show upregulation of
nicotinic receptors [18,19], a key biochemical hallmark
of smoking. Nicotinic receptor upregulation occurs in aentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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unclear whether nAChR upregulation is merely an epiphe-
nomenon or an actual contributor to addictive behaviour.
However, upregulation of α4* nAChRs on GABAergic
neurons of the VTA is implicated in behaviours of toler-
ance and craving of nicotine in chronically exposed mice
[7]. With regards to drug taking, craving induces a cycle
of administration and reinforcement to perpetuate drug
seeking, while tolerance causes heightened administration.
Abstinence from nicotine causes withdrawal, characterized
by both somatic illness [2,20-22] and cognitive deficits
[23-27]. Severity of withdrawal also correlates with nico-
tinic receptor upregulation [28] and symptoms are attenu-
ated by injection of nicotine [21]. Specifically, β2* nAChRs
and nAChR upregulation have been shown to be associ-
ated with cognitive withdrawal [24,27]. However, some
studies reported that nAChR upregulation is not corre-
lated with physical withdrawal symptoms but instead that
physical withdrawal depends on nAChRs containing α2,
α5 and β4 subunits and not β2 subunits [2,22]. Further-
more, physical symptoms of withdrawal appear to be
mediated by brain regions outside the VTA, including
the medial habenula – interpeduncular nucleus pathway
[22,29]. Thus, there are some conflicting data concerning
whether nAChR upregulation correlates with withdrawal,
but little is known about whether upregulation contributes
to heightened nicotine self-administration.
Oral self-administration, using drinking water as the ve-
hicle for drug administration, is a well established paradigm
for nicotine self-administration [16,30,31]. This method is
non-invasive and can also provide adequate means to study
the effects of nicotine intake in an episodic manner and
during periods following overnight abstinence, paralleling
that of compulsive tobacco users. In this study, using a two
bottle-choice of oral nicotine self-administration, we tested
the hypothesis that mice chronically pretreated with nico-
tine and having upregulated nAChRs will self-administer
more nicotine than mice that have normal receptor levels.
We also examined whether nicotine abstinence will per-
petuate elevated nicotine self-administration.
Methods
Mice
All experiments were conducted in accordance with the
guidelines for care and use of animals provided by the
Canadian Council on Animal Care Use. Mice were housed
at the University of Victoria Animal Care Unit and all pro-
tocols were approved by the University of Victoria Animal
Care Committee. Eight to 10 week old homozygous male
α4YFP knock-in mice were used in all experiments [7,32].
In the α4YFP knock-in mouse strain its α4 nAChR gene
was altered so that the coding cDNA sequence of the yel-
low fluorescent protein (YFP) was inserted into the M3-
M4 loop of the α4 nAChR subunit. The α4YFP* nAChRsfunction and express normally in every respect [7]. The
strain is back-crossed over 10 generations to C57BL/6 J.
Mice were housed on a 12 hour light/dark cycle at 22°C
and given a standard laboratory diet and water ad libitum,
except where noted in behavioural experiments.
Chronic nicotine administration via osmotic pumps
Chronic nicotine or saline was administered via implanted
osmotic pumps (model 2002; Alzet, cat# 7147090–12) with
a flow rate of 0.5 μl/h. Solutions, either nicotine or saline-
control, were prepared on the day of surgery and stored
in saline before implantation. Control pumps were filled
with saline (0.9% w/v, cat# S5815, Teknova). Nicotine-
containing pumps were filled with (−)-nicotine hydro-
gen tartrate (cat# N5260, Sigma) at a concentration to
deliver nicotine at 0.4 mg/kg/hr or 2 mg/kg/hr (calcu-
lated as free base of nicotine) for 10 days. Surgery was
performed as described in Renda and Nashmi [32]. The
10 day duration and amount of nicotine delivery (2 mg/
kg/h) via this method is sufficient to cause maximal
nAChR upregulation [33] and a blood nicotine concen-
tration of ~590 nM [34] which is near the peak concen-
tration of nicotine found in smokers’ blood.
Fixation and brain sectioning
Following 10 days of chronic nicotine administration
via osmotic pumps, mice were sacrificed and their
brains harvested for quantitative fluorescence imaging.
Mice were anesthetized via intramuscular injection of keta-
mine (100 mg/ml) and dexmedetomidine hydrochloride
(0.5 mg/ml) and intracardially perfused with 20 ml of PBS
(pH 7,6), followed by 30 ml of 4% paraformaldehyde in PBS
(pH 7.6, cat# 15710, Electron Microscopy Sciences) and fi-
nally with 5% sucrose in PBS (pH 7.6) in order to flush re-
sidual PFA and reduce autofluorescence. The brain was
then extracted and placed in 30% sucrose in PBS (pH 7.6).
After three days the brains were removed, submerged in O.
C.T. Mounting Compound (cat# 4583, Tissue-Tek), frozen
in dry ice and then stored at −20°C before slicing. Brains
were sectioned coronally (30 μm thick) on a cryostat (Leica
CM1860UV), transferred to coated slides (cat# 15-188-48,
Superfrost® Plus Gold, Fisher Scientific) kept in slide boxes
containing a calcium sulphate stone to prevent freezer burn
and stored in zip-lock bags at −20°C.
Immunohistochemistry
Brain sections on slides were washed twice with PBS
(pH 7.6) for 10 min, and then permeabilized with 0.25%
Triton for 5 min. The slides were washed twice again for
10 min with PBS, then blocked with 10% donkey serum in
PBS (cat# 017-000-121, Jackson ImmunoResearch) for
30 min. The primary antibodies (tyrosine-hydroxylase poly-
clonal antibody, cat# P4010-0, Pel-Freez; GAD67 monoclo-
nal antibody, cat# MAB5406, Millipore) were diluted in 3%
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bated for 60 min at 37°C. Slides were washed with PBS
three times for 5 min. The secondary antibodies (Alexa
Fluor 405 IgG secondary antibody, cat# A-31556, Invi-
trogen; Cy5 IgG secondary antibody, cat# 715-175-150,
Jackson ImmunoResearch Labs) were diluted in 3% don-
key serum in PBS, at a 1:200 concentration and incubated
for 60 min at 37°C. Brain slices were then washed with
PBS for 5 min three times. Brain sections were mounted
with 25 μl Vectashield Mounting Medium (cat# H-1000,
Vector Laboratories) and coverslipped.
Spectral confocal imaging
Image collection was performed as described in detail by
Renda and Nashmi [32]. Images were acquired using a
Nikon C1si spectral confocal system attached to a Nikon
Eclipse Ti-E inverted microscope. Samples were imaged
using a 60X oil CFI Plan Apo VC objective (1.40 NA,
0.13 mm working distance) and α4YFP was excited using
a 488 nm laser line of a 40 mW Argon laser at 15% max-
imum transmission, imaged at 4.08 μs pixel dwell time
and averaged over two scans through a 60 μm diameter
pinhole with spectral detector gain at 220. Alexa 405 sec-
ondary antibody was imaged with a 405 nm diode laser at
3.5% transmission and CY5 conjugated secondary anti-
body labeling was imaged with a 638 nm diode laser at 7%
transmission. We collected 50 μm × 50 μm z-stack images
through 30 μm thick tissue over a spectral range of
496.5 nm - 656.5 nm at 5 nm resolution. Thus a λ-stack of
images were acquired at 512 × 512 pixels. Hence, each
pixel of the X-Y image is comprised of a complete spectral
emission profile. The endogenous expression of the α4YFP
fluorophore in our mouse line allowed us to image the tis-
sue and avoid the confounds of antibody specificity and
penetration [32]. Settings remained constant during im-
aging of all brain sections and for each laser line the laser
power were checked with a power meter at the beginning
of each day’s experiment. A linear unmixing algorithm was
used to deconvolve specific YFP fluorescence from back-
ground autofluorescence based on the unique spectral
signatures of YFP imaged from soluble YFP transfected
HEK293T cells and brain regions from WT C57BL/6 J
mice. Once separated, autofluorescence is discarded and
the remaining image displaying values only pertaining to
YFP expression remains. Details of spectral unmixing are
provided in Renda and Nashmi [32].
Two bottle-choice nicotine self-administration
Individually housed α4YFP mice were implanted with ei-
ther saline or nicotine-containing osmotic pumps and
given standard food and water ad libitum for 10 days, as
above. On day 10 the pumps were removed via the ini-
tial incision site. Mice were anesthetized in order to re-
move the pumps in the same manner as described abovefor implantation. Two choices of drinking water (reverse
osmosis water (roH2O)) were then provided for 5 days,
one of which contained 200 μg/ml (−)-nicotine (Sigma,
cat# N3876). Bottles were constructed from 50 ml plas-
tic centrifuge tubes with rubber stoppers that were fitted
with metal spouts. A cage with no mice but with two
filled bottles were monitored daily to control for fluid
loss due to fluid evaporation and spillage. Both bottles
were sweetened with a vehicle: 0.2% saccharine (Sigma-
Aldrich, cat# 109185). The spout of each bottle was
labeled with either white or black tape to indicate which
solution (nicotine or vehicle) was present in order to
reduce drinking variability due to the animal trying to
determine the contents of each bottle. This was random-
ized so that an equal number of mice were drinking
nicotine labeled with black tape as white tape within the
saline pump group of mice and within the nicotine pump
group of mice. The two choice-bottles were placed beside
each other, with food occupying the remaining portion of
the wire cage-top. We randomized the placement of the
nicotine bottle for each mouse and ensured an equal num-
ber of nicotine bottles in the lateral vs middle position
within each group (nicotine or saline) to avoid any poten-
tial mouse bias for bottle position. Once spout color and
bottle position were assigned to the nicotine and vehicle
bottles, the bottle position and spout color assignment
remained the same throughout the experiment for each
mouse. The spout color and bottle position were cues that
the mouse could associate whether the bottle contained
nicotine or saccharine water. The rationale is that predict-
ive cues have been shown to be effective in enhancing
nicotine self-administration in rodents [35]. After five days
of choice, the nicotine and vehicle bottles were removed
and replaced with an identical bottle with an untaped
spout containing only roH2O in order to induce with-
drawal from nicotine. After three days of abstinence, the
mice were put back on the two bottle-choice setup for
four days, followed again by three days of abstinence. This
weekly cycle continued for five total periods of choice, in-
cluding the first period following pump removal. Mice
were weighed on the second day of each abstinence period
to minimize the effects of stress on their nicotine con-
sumption. Bottles were weighed each day and replaced
with fresh solutions. Nicotine consumption was recorded
every 24 h as a daily dose (mg nicotine/kg mouse) and the
mouse weight used in the dose calculation was an average
of the weight measurements taken during the abstinence
period prior to and following the period of choice in
question. Nicotine consumption was also recorded as
the amount of fluid consumed from the bottle contain-
ing nicotine as a percentage of the animals’ total daily
fluid intake. Note that during the day of pump removal
surgery, even though mice were presented with a choice
of two bottles, drinking volumes were not included in
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gery (Figure 1).
Statistical analysis
All values are reported as mean ± standard error of the
mean (SEM). Statistics were performed using the R Project
for Statistical Computing language (www.r-project.org).
To compare statistical difference between two groups of
data a t-test was performed provided the data met para-
metric requirements of normality (Shapiro-Wilk normality
test) and equal variance (Fligner-Killeen test of homogen-
eity of variances). Otherwise, the non-parametric equiva-
lent, the Wilcoxon rank sum test, was performed. For
comparison of three or more groups a one-way analysis of
variance (ANOVA) was used for parametric data and a
Kruskal-Wallis rank sum test was used for non-parametric
data. A two-way ANOVA was performed on data with
two factor variables. A Bonferroni correction was per-
formed as a post-hoc pair-wise analysis on data deemed
significant by either one-way or two-way ANOVA. A
Wilcoxon rank sum test was used as post-hoc pair-wise
analysis on data deemed significant using the Kruskal-
Wallis rank sum test. Groups of data were calculated to




roH2O + vehicle (0.2% saccharine)
roH2O + vehicle (0.2% saccharine) + 200 ug
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Figure 1 Two bottle-choice administration schematic and time frame
B) During periods of choice mice are presented with bottles in X and Y, bo
bottle will contain 200 μg/ml nicotine (green) and the second will contain
containing bottle is randomized. The spout of each bottle is randomly labe
to taste-testing. Food is placed in the unoccupied third of the wire cage to
containing only roH2O (blue). It is placed in Z and the food is moved to X
implanted with osmotic pumps containing nicotine or saline, for ten days,
pump is removed and the mice are subjected to periods of two bottle-cho
vehicle), followed by 3 days of abstinence (white: 1 bottle containing roH2OResults
Chronic nicotine administered via pumps upregulates
α4YFP nAChRs
Nicotinic receptor upregulation is a biochemical hall-
mark in the brains of smokers and chronic nicotine infu-
sion in mice can upregulate nAChRs in various brain
regions. However, it is unclear whether nAChR upregu-
lation plays any role in nicotine addiction. We hypothe-
sized that mice pretreated with chronic nicotine at a
dosing regimen sufficient to upregulate nicotinic recep-
tors would self-administer a higher dose of nicotine as
compared to control mice, which receive a pretreatment
of chronic saline. Hence, we looked for evidence of an
addictive behaviour that would correlate with nicotine
pretreatment and receptor upregulation. To test our hy-
pothesis, we pretreated mice with chronic nicotine via
an osmotic pump implanted subcutaneously that deliv-
ered nicotine at 2 mg/kg/hr for 10 days. We first con-
firmed that the chronic nicotine exposure via the pump at
our dosing regimen caused upregulation of α4* nAChRs
in specific brain regions.
Previously, we and others have shown that chronic
nicotine delivery results in a region specific upregulation
of α4* nAChRs [6,7,16,17]. Specifically, we demonstrated
that 10 days of chronic nicotine delivery at 2 mg/kg/hr/ml nicotine
 Abstinence
Choice: 2 Bottle (nicotine or vehicle)
Abstinence: 1 Bottle (roH2O)
  C
W3 W4 W5
1 2 3 4 1 2 3 4 1 2 3 4
. A) The wire cage top can be divided into three sections (X | Y | Z).
th of which contain roH2O and the vehicle: 0.2% saccharine. One
only vehicle (red). Lateral (X) or medial (Y) placement of the nicotine-
led black or white as a visual cue to reduce nicotine consumption due
p, Z. C) During abstinence, the mice are given a single bottle
| Y. The spout of the abstinence bottle is unlabeled. D) Mice are
with access to a standard laboratory diet and water. On day ten the
ice (grey: 0.2% saccharine in roH2O containing either nicotine or
). Cycles of choice and withdrawal continue for an additional 4 weeks.
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the medial perforant path of the hippocampus (94 ± 2%),
whereas the medial habenula (MHb) was unaffected by
the drug (12 ± 4%) [7]. Thus, the medial perforant path
and the MHb are used as positive and negative controls,
respectively, to examine nicotine induced α4YFP upreg-
ulation. We have replicated those results, with chronic
nicotine causing an 89 ± 16% upregulation of α4YFP in
the medial perforant path (p = 0.001, Wilcoxon rank-
sum test) while causing no significant α4YFP nAChR
upregulation in the MHb (14 ± 17% upregulation, p =
0.3, two sample t-test) (Figure 2C,D) when compared to
control mice in which osmotic pumps delivered saline
for 10 days.
Nashmi and colleagues [7] were the first to investigate
cell-type specific changes of neuronal nAChRs in the











































Figure 2 Changes in α4YFP nAChR expression in the medial
habenula and the hippocampal medial perforant path.
A) Montage of images of α4YFP nAChR expression in the medial
perforant path and medial habenula (MHb) in a coronal mouse brain
section. B) Chronic nicotine does not affect α4YFP nAChR expression
in the MHb (14 ± 17% upregulation, p = 0.3, t-test). C) Chronic
nicotine results in upregulation of α4YFP nAChRs in the medial
perforant path (89 ± 16% upregulation, p = 0.001, Wilcoxon rank
sum test) in mice.a 36 ± 7% receptor upregulation in ventral tegmental area
(VTA) GABAergic neurons but no upregulation on dopa-
minergic soma. Here, we measured the mean α4YFP fluor-
escence in each individual GABAergic and dopaminergic
cell body by co-immunostaining for GAD67 and tyrosine
hydroxylase, respectively. We showed similar results to
the previous study: chronic nicotine caused a 57 ± 10% up-
regulation on GABAergic somata (p = 0.005, t-test) but no
upregulation (−8 ± 8%) on dopaminergic somata (p = 0.5,
Wilcoxon rank sum test) of the VTA when examined from
Bregma −2.92 mm to −3.16 mm (Figure 3).
Imaging the brains of α4YFP mice exposed to chronic
nicotine or chronic saline via osmotic pumps and quanti-
fying fluorescence yielded cell specific patterns of α4YFP
nAChR upregulation in specific brain regions. Table 1
compares our fluorescence intensity values of α4YFP ex-
pression following chronic nicotine exposure as a percent-
age of α4YFP expression in nicotine naïve mice (saline
pump), with those obtained by Nashmi et al. [7]. This
study was successful in replicating receptor expression
level changes, following exposure to chronic nicotine, in
specific brain regions and neuronal cell types as in Nashmi
et al. [7]. Furthermore, the magnitude of the percentage of
receptor upregulation in different brain regions was nearly
identical in both studies. Therefore, these data validate the
quantification of α4* nAChRs performed in this study.
Effect of two bottle-choice nicotine self-administration on
bottle position preference, animal weight and daily fluid
intake
To ensure bottle preference was not biased towards spout
colour or bottle location, six mice were implanted with
pumps containing saline for 10 days and then subjected to
the two bottle-choice paradigm (Figure 1). During periods
of choice each bottle contained only vehicle (roH2O +
0.2% saccharine), one with a white spout and one labeled
black. Positions of the bottles were randomized so that
half the mice (n = 3) had their laterally positioned bottle
labeled black while the other half (n = 3) had their medial
bottle labeled black. Regardless, neither group showed any
preference for bottle position (lateral or medial) nor spout
colour (black or white) (lateral black spout: p = 0.13,
Wilcoxon rank sum test; medial black spout: p = 0.60,
Wilcoxon rank sum test) (Figure 4).
The initial weights of each group of mice were not sig-
nificantly different (Day 0, p = 0.82, two sample t-test with
Bonferroni correction), and although both groups gained a
significant amount of weight over the test (saline pump,
p = 0.02, n = 13; nicotine pump, p = 0.008, n = 14, paired
t-tests with Bonferroni correction), the animals’ weights
on the final day of self-administration was not different,
indicating that neither nicotine pump mice nor saline
pump mice had their body mass differentially affected by
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Figure 3 Chronic nicotine increases expression of α4* nAChRs on GABAergic somata of the ventral tegmental area (VTA). A-C) Low
magnification images showing α4YFP expression (green) in dopaminergic neurons (TH, magenta) in the VTA. D-F) Higher power images showing
immunohistochemical labeling of α4YFP (green) (D) on GABAergic (GAD67, red) (E) and dopaminergic (TH, magenta) (F) neurons of the VTA.
G) Merged image showing α4YFP expression on a TH positive and a GAD67 positive neurons. H) Chronic nicotine causes an upregulation
(57 ± 10%) of α4YFP* nAChRs on GABAergic somata of the VTA (p = 0.005, two sample t-test) as compared to saline controls, but α4YFP
expression in dopaminergic neurons are unaffected (−8 ± 8%) (p = 0.5, Wilcoxon rank sum test). All n values are the total number of neurons
imaged and analyzed from 5 nicotine pump mice and 5 saline pump mice.
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Fluid consumption was very similar for both nicotine and
saline pump mice (Figure 5B,C). There was no difference
in daily fluid volume consumed between saline pump and
nicotine pump mice during choice (p = 0.10) or abstinence
(p = 0.99, Wilcoxon rank sum tests with Bonferroni cor-
rection). Neither did either group consume different fluid
volumes during choice or abstinence (saline pump, p =
0.68; nicotine pump, p = 0.77, Wilcoxon rank sum tests
with Bonferroni correction) (Figure 5B). However, once the
slight differences in body weight are taken into account, we
see that nicotine pump mice consumed a significantly largerTable 1 Changes in α4YFP* nAChR expression with chronic ni
compared to Nashmi et al. [7]





ns = not significantly different from saline treated animals.daily total fluid dose normalized to body weight (ml/kg)
as compared to saline pump mice during periods of choice
(p = 0.018) and abstinence (p = 0.035), although neither the
saline pump mice nor the nicotine pump mice consumed
more fluid during choice vs abstinence (saline pump, p =
0.23; nicotine pump, p = 0.98, Wilcoxon rank sum tests
with Bonferroni correction) (Figure 5C). Both groups of
mice, nicotine pump and saline pump, steadily decreased
their total volume of fluid intake over the course of the
two-bottle choice experiment from day 1 to day 20 (nico-
tine pump: R2 = 0.70, p < 0.0001, linear regression; saline
pump: R2 = 0.61, p = 0.0003, linear regression) (Figure 5D).cotine exposure in α4YFP knock-in mice in this study as
α4YFP* nAChR Upregulation (% of saline)
This study Nashmi et al. [7]
189 ± 16 (p = 0.001) 194 ± 2 (p < 0.001)
114 ± 17 (ns) 112 ± 4 (ns)
157 ± 10 (p = 0.005) 136 ± 7 (p = 0.002)





















Figure 4 Mice showed no preference for bottle position or
spout colour. Control mice (n = 3 for each setup A and B) were
implanted with saline-containing pumps for 10 days and then
subjected to the two bottle-choice paradigm. Both bottles contained
only vehicle (roH2O sweetened with 0.2% saccharine (red)) and the
spout was labeled either black or white, as depicted in A and B.
Bottles were randomized so that half the mice had their laterally
positioned bottle (L) labeled black and half had their medial
positioned bottle (M) labeled black. Neither group showed any
preference for bottle position or spout color (A: p = 0.13, Wilcoxon
rank sum test, n = 3; B: p = 0.60, Wilcoxon rank sum test, n = 3).
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more nicotine than nicotine naïve mice
Following 10 days of either nicotine or saline pretreat-
ment with an osmotic pump implant, the mice were ex-
posed to a two bottle-choice paradigm. At the end of the
tenth day of pump implantation, the pumps were re-
moved and the mice were subjected to five repeating cy-
cles of two bottle-choice (4 days, nicotine or vehicle)
and abstinence (3 days, water). We examined whether
mice that had received nicotine chronically and steadily
via an osmotic pump at a dosing regimen which was suf-
ficient to induce α4* nAChR upregulation, will choose to
self-administer more nicotine and/or show a significant
degree of behavioural nicotine reinforcement.
Figure 6 shows the drinking pattern of mice who were
implanted with a nicotine pump (2 mg/kg/hr for 10 days,
n = 14) or saline pump (n = 13) and then subjected to
five weekly cycles of four days choice (vehicle or 200 μg/
ml nicotine + vehicle; vehicle being saccharine sweetened
water) followed by three days of withdrawal (roH2O).
Nicotine pump mice (n = 14) self-administered signifi-
cantly higher doses of nicotine (p = 0.0496, F(1, 23) = 4.30,
pump factor effect, two-way mixed ANOVA) throughoutthe five week duration of the two bottle-choice experiment
and reaching significance during week 1 (W1), week 3
(W3) and week 5 (W5) of the two-bottle choice experiment
(W1, p = 0.002; W3, p = 0.04; W5, p = 0.01; Bonferroni
post-hoc analyses) as compared to the control saline
pump mice at the same respective time points (n = 13)
(Figure 6A,B). Furthermore, there was a significant change
in nicotine self-administration over the days of the experi-
ment (p = 0.006, F(19, 462) = 2.04, day factor effect, two-
way mixed ANOVA). However, there was no interaction
effect on nicotine self-administration between the day of
the experiment and the type of pump implanted (p = 0.73,
F(19, 462) = 0.78, pump x day effect, two-way mixed
ANOVA). We noted that nicotine pump mice showed an
elevated though gradual decrease in their daily dose of
nicotine (day 1- day 20: R2 = 0.47, p = 0.0008, linear re-
gression) while saline pump mice maintained a steady
dose of nicotine throughout the days of choice (day 1-
day 20: R2 = 0.07, p = 0.3, linear regression).
Next, we analyzed the effects of three day nicotine
deprivation on nicotine self-administration following the
abstinence period by examining the trend in nicotine
consumption within each of the four days of choice aver-
aged over the five weeks (day 1, W1-W5; day 2, W1-W5;
day 3, W1-W5; day 4, W1-W5) (Figure 6C). Nicotine
pump mice showed a significant transient elevation in
their nicotine consumption on the first day (p = 0.03,
Wilcoxon rank sum test) of nicotine choice following
abstinence as compared to saline pump mice, followed
by a decline in nicotine consumption over the next three
days (days 2–4) of the choice period (Figure 6C). This
trend is observed only in animals primed with a nicotine
pump (R2 = 0.77, p = 0.01, linear regression). Further-
more, all four days of nicotine consumption in the nico-
tine pump mice were elevated as compared to the saline
pump mice. Saline pump mice consumed a constant
dose of nicotine during each day of choice (R2 = 0.70,
p = 0.56, linear regression).
Mice control their daily fluid intake closely; during pe-
riods of choice their total fluid volume is composed of
fluid from each of two bottles: vehicle or 200 μg/ml
nicotine + vehicle. We examined the percentage of their
total fluid intake that is allocated to the bottle which
contains nicotine (Figure 7). During week 1 (W1), the
mice primed with a nicotine pump drank a significantly
higher percentage of total fluid from the nicotine bottle
(p = 0.0002, F(1, 487) = 14.2, pump factor effect, two-way
ANOVA; p = 0.01 for W1, Bonferroni post-hoc analysis)
as compared to the bottle containing only saccharine
sweetened water (Figure 7B). During subsequent weeks
(W2-W4), the percentage of daily fluid consumed from
the nicotine bottle was not significantly different between
the nicotine and saline pump animals. There was neither a
















































































































Abstinence      Choice
Figure 5 Effect of a two bottle-choice nicotine self-administration assay on bottle preference, animal weight and daily fluid intake.
A) Mice in both groups that were either implanted with saline pumps or nicotine pumps displayed significant increase in body weight from day
0 to day 20 over the course of the nicotine self-administration experiment. However, there was no significant difference in body weight between
saline pump and nicotine pump mice either on day 0 or on day 20 of the experiment. B) There was no difference in daily fluid volume (totaled
for both bottles, ml) consumed between the choice or abstinence periods in either the saline pump mice or the nicotine pump mice.
Furthermore, there was no difference in fluid volumes consumed between saline pump mice and nicotine pump mice during choice or
abstinence. C) Daily fluid intake normalized to animal body weight (totaled for both bottles, ml fluid/kg mouse) showed that nicotine pump mice
consumed a significantly larger daily total fluid dose compared to saline pump mice during periods of choice and also during periods of
abstinence, although neither the nicotine pump mice nor the saline pump mice consumed more fluid during choice as compared to during
abstinence. D) Both the saline pump and nicotine pump mice showed a linear trend of decreased total fluid intake over the 20 days of the
self-administration experiment (saline pump: dashed line, R2 = 0.61, *p = 0.0003, linear regression) (nicotine pump: solid line, R2 = 0.70, **p < 0.0001,
linear regression).
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nor an interaction between pump and day effect on
the percentage volume of nicotine consumed (p = 0.92,
F(19, 487) = 0.57, pump x day factor effect, two-way
ANOVA). When we examined their nicotine volume as
a percent of total fluid volume across all days of choice,
we found that, overall, mice primed with nicotine pumps
drank a significantly larger portion of their daily fluid
intake from the nicotine-containing bottle as com-
pared to the saline pump mice (p = 0.002, Wilcoxon
rank sum test) (data not shown).
Within each week, the nicotine pump mice showed a sig-
nificant initial surge in fluid consumption from the nicotine-
containing bottle on day one (p = 0.03, t-test) as compared
to the saline pump mice on day one and followed by a
steady decline during the next three days in their nicotineconsumption as a percentage of total fluid volume (R2 =
0.76, p = 0.01, linear regression). The saline pump mice con-
sumed a steady (R2 = 0.36, p = 0.19, linear regression) and
lower percentage of their daily fluid volume from both bot-
tles across all four days of choice as compared to nicotine
pump mice. These results indicate that three days of abstin-
ence resulted in binge drinking of nicotine immediately
upon resumption of the nicotine and water choice bottles.
To examine whether nicotine self-administration corre-
lates with nAChR upregulation we performed an experi-
ment involving three groups of mice chronically exposed
to different concentrations of nicotine via osmotic pumps:
1) saline (0 mg/kg/hr nicotine), 2) 0.4 mg/kg/hr nicotine,
and 3) 2 mg/kg/hr nicotine. Following the 10 days of sa-
line or nicotine pump administration, the pumps were re-
moved and mice underwent 5 days of two bottle-choice of
** Saline Pump (n=13)
Nicotine Pump (n=14)
Day          1  2  3  4      1  2  3  4            1  2  3  4              1  2  3  4            1  2  3  4     





























































































Figure 6 Chronic nicotine pump mice self-administer a greater amount of nicotine and display a surge in nicotine consumption following
abstinence. A) Following 10 days of chronic drug administration via osmotic pumps (2 mg/kg/hr nicotine or saline), mice are subjected to five 7 day
cycles of choice (4 days, two bottle: vehicle (0.2% saccharine) or vehicle + 200 μg/ml nicotine) followed by abstinence (3 days, single bottle roH2O).
During choice period, nicotine primed mice consumed a greater dose of nicotine than saline pump mice (p 0.0496, pump factor, two-way mixed
ANOVA). Mice implanted with a nicotine pump (n = 14) self-administered more nicotine during W1 (*p = 0.003, pump factor, two-way ANOVA), W3
(**p = 0.02, pump factor, two-way ANOVA) and W5 (***p = 0.006, pump factor, two-way ANOVA). B) Mean nicotine dose averaged each week of two
bottle-choice self-administration showed that on a weekly basis nicotine pump mice self-administered a significantly higher level of nicotine than saline
pump mice (p = 0.0496, pump factor effect, two-way mixed ANOVA; W1, p = 0.002; W3, p = 0.04; W5, p = 0.01, Bonferroni post-hoc analysis).
C) Nicotine binge-drinking following abstinence from nicotine self-administration occurred only in the nicotine pump mice. In nicotine pump mice
there was elevated nicotine consumption the day following abstinence followed by a steady decline thereafter in the next three days of choice
(Solid line: R2 = 0.77, *p = 0.01). Saline pump mice consumed a lower dose throughout each day of the choice period (dashed line: R2 = 0.70,
p = 0.56). Nicotine pump mice also showed a significant transient elevation in their nicotine consumption on the first day (p = 0.03, Wilcoxon rank sum
test) following abstinence as compared to saline pump mice.
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http://www.biomedcentral.com/1471-2202/15/89oral nicotine self-administration. There was a strong linear
positive correlation of the dose of nicotine administered
through the pumps and the degree of oral nicotine self-
administration (R2 = 0.994) (Figure 8A). We then examined
whether oral nicotine self-administration in the three
groups of mice correlated with α4YFP nAChR subunit up-
regulation in three different brain regions: the medial per-
forant path of the hippocampus, GABAergic neurons of the
VTA and GABAergic neurons of the substantia nigra (SNR).
Since we closely replicated nicotine induced expression
changes of α4YFP nAChR subunits at 2 mg/kg/hr to our
previous study (Table 1) [7], we used the α4YFP expressiondata for saline, 0.4 mg/kg/hr nicotine and 2 mg/kg/hr nico-
tine from Nashmi et al. [7] to correlate with oral nicotine
self-administration in this study from mice undergone the
same dosage of nicotine pump administration (0, 0.4 and
2 mg/kg/hr for 10 days) (Figure 8B-D). We found that oral
nicotine self-administration displayed a strong positive cor-
relation with α4YFP nAChR subunit upregulation in all
three brain regions with the highest correlation in GABAer-
gic neurons of the VTA (VTA: R2 = 0.9999; SNR: R2 =
0.988; medial perforant path: R2 = 0.952). These results pro-
vide supporting evidence suggesting that α4* nAChR up-
















4Day 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3
































1        2 3 4

























































Figure 7 Mice pre-exposed with chronic nicotine self-administer a greater percentage volume of their daily fluid from the nicotine
containing bottle in a two-bottle choice experiment. A) Mean nicotine volume intake as a percentage of total fluid volume during each
period (days 1–4 during weeks 1–5) of two bottle-choice self-administration. Following 10 days of chronic drug administration via osmotic pumps
(2 mg/kg/hr nicotine or saline), mice were subjected to five 7 day cycles of choice (4 days, two bottles: vehicle (0.2% saccharine) or vehicle +
200 μg/ml nicotine) followed by abstinence (3 days, single bottle roH2O). Mice primed with a nicotine containing pump self-administered more
fluid from the nicotine bottle during most days of choice, though reached statistical significance only on W1 (*p = 0.0002, pump factor, two-way
ANOVA; p = 0.01, Bonferroni post-hoc analysis). B) On a weekly basis, nicotine primed mice drink more fluid from their nicotine bottle than control
saline primed mice, although significance was only achieved on W1 (p = 0.0002, pump factor, two-way ANOVA; p = 0.01, Bonferroni post-hoc
analysis). C) Nicotine binge-drinking results from abstinence from nicotine self-administration. Percentage of daily fluid drank from the nicotine-
containing bottle peaked on the first day following abstinence from nicotine self-administration and declined in subsequent days, a behaviour
seen only in mice primed with a nicotine pump (day 1–4) (solid line: R2 = 0.76, **p = 0.01, linear regression,). Saline pump mice maintained a
steady and lower percentage intake from their nicotine-containing bottle during each day of choice (dashed line: R2 = 0.36, *p = 0.19, linear
regression). Furthermore, nicotine-pump mice self-administered significantly more nicotine compared to saline-pump mice on the first day
following abstinence (p = 0.03, two sample t-test).
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In this study we examined whether nicotinic receptor up-
regulation correlates with oral self-administration of nico-
tine by comparing nicotine drinking behaviour in mice
pretreated with chronic nicotine via an osmotic pump as
compared to chronic saline controls. Ten days of chronic
nicotine treatment (2 mg/kg/hr) via osmotic pumps resulted
in significant upregulation of α4 nAChR subunits in the hip-
pocampal medial perforant path and GABAergic neurons of
the VTA in α4YFP knock-in mice. The upregulation was
cell type specific since there was neither upregulation in the
medial habenula nor on dopaminergic neurons in the VTA.
Chronic nicotine pretreated mice consumed a significantlygreater daily dose of nicotine as compared to mice pre-
treated with saline and varying doses of chronic nicotine
pretreatment linearly correlated with both the degree of
nicotine self-administration as well as nAChR upregulation.
Furthermore, following three days of abstinence the nicotine
pretreated group of mice consumed significantly elevated
nicotine levels during the first day of choice. These results
are consistent with the notion that nicotinic receptor upreg-
ulation may contribute to nicotine dependence.
α4* nAChR upregulation is brain region and cell type specific
We show that quantitative fluorescence imaging pro-
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0.4 mg/kg/hr                         
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0.4 mg/kg/hr                         
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Figure 8 Pretreatement with chronic nicotine and α4* nAChR upregulation correlate with nicotine self-administration. Mice implanted with
osmotic pumps (saline (n = 3), 0.4 mg/kg/hr (n = 5) or 2 mg/kg/hr nicotine (n = 4)) for 10 days were subjected to two-bottle choice nicotine self-
administration for 5 days following pump removal. A) Pretreatment with nicotine correlates with mean daily dose of self-administered nicotine (R2 = 0.994,
p = 0.01, linear regression). Osmotic pump treatment with 0.4 or 2 mg/kg/hr nicotine for 10 days results in a progressively greater amount of α4YFP nAChR
upregulation as compared to treatment with 0 mg/kg/hr (% of saline). The α4YFP nAChR upregulation data for the three doses were taken from Nashmi
et al. [7] and show that oral self-administration strongly correlates with upregulation in GABAergic neurons of the VTA (B) (R2 = 0.9999), GABAergic neurons
of the substantia nigra pars reticulata (SNR) (C) (R2 = 0.988) and the medial perforant pathway of the hippocampus (D) (R2 = 0.952).
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http://www.biomedcentral.com/1471-2202/15/89type and brain region specific nAChR upregulation. Util-
izing the protocol described by Renda and Nashmi [32],
we have reproduced quantitatively very similar levels of
nicotinic receptor upregulation in specific neuronal cell
types and brain regions as first described by Nashmi and
colleagues [7].
The medial perforant path of the hippocampus shows
improvement of long term potentiation induction following
application of chronic nicotine [7], which may account for
improvements in learning and memory seen in smokers
and chronically exposed mice [36]. The medial habenula is
related to nicotine aversion and plays a role in withdrawal
from chronic nicotine [22,37]. Both the medial perforant
path and the medial habenula express α4* nAChRs, al-
though only the medial perforant path shows nAChR
upregulation in response to chronic nicotine, while the ex-
pression of α4* nAChRs in the medial habenula is un-
changed. The VTA is strongly linked to nicotine addiction
[4,15,38,39]. Although both dopaminergic and GABAergicneurons of the VTA express α4* nAChRs, upregulation is
restricted to GABAergic neurons. However, the increase in
nicotinic receptors confers an increase in GABAergic inhib-
ition of dopaminergic activity which subsequently decreases
the reward output of the VTA. This is hypothesized to ac-
count for the addictive behaviours of craving and tolerance
in nicotine addicts [7]. Our fluorescence imaging results
suggest that mice pretreated with nicotine via osmotic
pumps may be tolerant to nicotine due to GABAergic spe-
cific nAChR upregulation in the VTA. Therefore, it stands
to reason that if upregulation plays a role in nicotine de-
pendence and self-administration these mice would need to
intake a larger dose of nicotine, compared to nicotine naïve
mice, to experience reinforcement.
Chronic nicotine pretreatment enhances nicotine
self-administration
We sought to address the question of whether chronic nico-
tine pre-exposure can influence the choice to self-administer
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tion via osmotic pumps at 2 mg/kg/hr is sufficient to con-
sistently upregulate α4* nAChRs in the hippocampus and
VTA, we placed pretreated mice into a two bottle-choice
self-administration paradigm. Since we have coupled drug
administration with fluid intake, providing the animal with
a choice is crucial in order to investigate the more subtle
behaviours contributing to addiction and making accurate
inferences about how molecular changes following nico-
tine exposure influence the choice to self-administer
nicotine.
Mice pretreated with chronic nicotine self-administered
a greater daily dose of nicotine throughout the 20 days of
exposure (Figure 6A). Self-administration of nicotine is ab-
sent in both α4 and β2 KO mice but selective re-expression
of the knocked-out subunit (either α4 or β2) in the VTA of
KO mice re-establishes nicotine self-administration [5,15],
which forges a strong link between the activity of these
subunits and nicotine dependence. Our data suggest that
in addition to α4β2 nAChRs governing nicotine self-
administration, the level of α4* nAChR expression can in-
fluence the magnitude of a mouse’s propensity towards
nicotine self-administration. At this point our data is con-
sistent with the hypothesis that nicotinic receptor upregu-
lation is contributing to the heightened self-administration
of nicotine in mice. However, to unequivocally test
this hypothesis further experiments would need to be
performed to knock-down nicotinic receptor expression
during chronic pretreatment of nicotine to determine
whether it is α4* nAChR upregulation or an ancillary ef-
fect of nicotine that is essential for nicotine dependent be-
haviour. Molecular and genetic tools such as shRNA,
knock-out mice and conditional transgenic mice can shed
light onto this question. One potential caveat is that oral
nicotine self-administration may be driven by different fac-
tors as compared to i.v. or intra-VTA self-administration.
Furthermore, it is not yet known whether deletion of α4
or β2 subunits would have the same effect of attenuating
oral self-administration of nicotine as had been found for
i.v. and intra-VTA self-administration [4,5,15] though de-
letion of the β2 nAChR gene did not appear to alter forced
nicotine drinking in mice [40]. Therefore, future studies
using nicotine two bottle-choice oral self-administration
experiments with α4 and β2 KO mice would need to be
performed in order to further elucidate the role of these
specific subunits in nicotine self-administration.
Mice pretreated with chronic nicotine exhibit abstinence
induced binge-drinking
The data presented in Figure 6C showed that abstinence
from nicotine for three days following a choice period re-
sults in significantly elevated nicotine self-administration
on the first day following abstinence and a gradual decline
over the next three days of choice in nicotine pump mice,a behaviour which was absent in saline pump mice. This
elevation in drinking levels may be due to binge-drinking
as a means to relieve withdrawal symptoms. This is con-
sistent with the results of Damaj and colleagues [21], who
showed that somatic withdrawal signs in mice peak be-
tween 2 and 3 days following removal of osmotic pumps
chronically infusing nicotine at 48 mg/kg/day over 15 days.
Withdrawal can be divided into three broad categories:
physical, affective and cognitive withdrawals. Each
yields different symptoms, although the cognitive defi-
cits linked to nicotine withdrawal are thought to be me-
diated by α4β2 nAChRs [24-27] and produce strong
negative reinforcement which decreases reward signals
[41]. Abstinence causes a drug-binge once nicotine is
reintroduced to the animal [12,42]. We show that
nicotine-primed mice ingest a significantly higher nico-
tine dose on the first day following abstinence, com-
pared to control mice, and that these values decrease
over subsequent days of choice. Binging is absent in the
control mice also provided with the two bottle-choice.
We propose that cognitive deficits and affective and
physical discomfort elicited by abstinence from nicotine
decrease in severity as upregulation declines following
removal of forced nicotine delivery via pump [41,43],
which induces maximal nAChR upregulation. Nicotine
craving, linked to nAChR upregulation, may be exacer-
bated by the negative reinforcement of withdrawal,
causing the mice to consume more nicotine immedi-
ately following abstinence.
A study by Hillario and colleagues [44] showed that
there was increased brain reward function in mice with re-
peated cycles of withdrawal, which initially appears to
contradict our results of the declining levels of enhanced
nicotine self-administration of nicotine pump mice over
time. In the study by Hilario et al. they continuously in-
fused nicotine at 24 mg/kg/day over 14 days followed by
4 days of single nicotine injections (0.5 mg/kg) and 4 days
of withdrawal. This cycle was repeated three times so a
total of 42 days of chronic nicotine was delivered by os-
motic pumps before the third withdrawal period and the
last nicotine pump delivery was only 4 days prior to the
start of the withdrawal period. The repeated pump deliv-
ery of nicotine showed the greatest level of nAChR upreg-
ulation by the third cycle of nicotine administration and
resulted in elevated reward brain function in the nicotine
pump mice. Although our study also had repeated periods
of withdrawal, the experimental paradigm of Hilario et al.
differed markedly from our study, in which only one con-
tinuous application of 10 days of nicotine (2 mg/kg/hr)
was delivered via osmotic pumps and that following the
third cycle of withdrawal in our study oral nicotine self-
administration was measured 21 days following the last
day of mini-pump nicotine administration. Therefore,
both studies are consistent in that for our study nicotinic
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week, during which we saw the largest degree of nicotine
self-administration, and receptor levels would decline over
time proportional to the level of self-administration, which
may explain the diminished but still heightened nicotine
self-administration in nicotine pump mice as compared to
the saline pump control mice over time. Hilario and col-
leagues also showed the importance of nAChR upregula-
tion, which peaked during the third cycle of withdrawal
and correlated with enhanced brain reward function.
Therefore, both studies are consistent, albeit using differ-
ent methods, in showing the significance of nAChR upreg-
ulation in behaviours related to nicotine dependence.
Role of nAChR upregulation in nicotine self-
administration
Pretreating with chronic nicotine is a novel feature of self-
administration paradigms. Cocaine had been used for a
similar rationale to train the mice to expect a drug-induced
reward in order to study addictive behaviours [45]. We
have adapted a similar principle, but unlike pre-exposure
with a drug like cocaine, which would instill an addiction
via different molecular pathways, we have primed our mice
with nicotine and have therefore elicited a biochemical
change that is nicotine-dependent and can implicate nico-
tinic receptor upregulation as a contributor of elevated
self-administration observed in pretreated mice.
Using three different concentrations of chronic nicotine
pretreatment (0, 0.4 and 2 mg/kg/hr nicotine) via osmotic
pumps we have shown a strong positive linear correlation
of nicotine dose and oral nicotine self-administration
(Figure 8A). Moreover, these three different doses of nico-
tine pretreatment resulted in a strong positive correlation
between α4YFP nAChR upregulation and oral nicotine
self-administration in three different brain regions (hippo-
campal medial perforant path, VTA GABAergic neurons,
SNR neurons) (Figure 8B-D). Interestingly, oral nicotine
self-administration showed the highest positive correlation
with α4YFP nAChR upregulation in GABAergic neurons
of the VTA, a brain region important for reward and
strongly implicated in addiction of drugs of abuse.
The data in Figure 6A show that the nicotine primed
mice are gradually decreasing their daily nicotine dose,
suggesting that they are unable to administer a large
enough dose to satiate the craving of such a high receptor
level instilled by the pumps without succumbing to the
negative side-effects of a nicotine overdose. We speculate
that the nicotine the pretreated mice ingest each day may
be providing the maximum satisfaction to withdrawal ratio
while their receptors normalize to a steady level consistent
with their maximum daily nicotine consumption.
Conversely, the saline pump mice have gradually in-
creased the amount of fluid consumed from the nicotine-
containing bottle over the course of the experiment inorder to maintain a steady daily dose of nicotine, which
they accomplish despite a weight increase – suggesting
that they are experiencing consistent reinforcement, befit-
ting what is known as the Boundary Model [46]. Human
smokers are subdivided into two groups: nicotine-addicted
heavy smokers and chippers – light smokers who show
few signs of addiction. Both groups smoke regularly and
in similar patterns, although light smokers do not become
tolerant, they maintain a constant, unchanging daily dose.
Heavy smokers, however, become tolerant to the effects of
nicotine over time and subsequently increase their daily
nicotine dose. Mice behave similarly; they are habitual in
that they actively maintain a constant dose of nicotine by
adjusting their consumption from the nicotine-containing
bottle over time, suggesting that they are satisfied without
becoming tolerant and having to increase their daily dose.
We argue that both groups of mice are exhibiting signs of
dependent behaviour and that it is possible they are both
converging on a similar satisfactory nicotine dose. Mice
not pretreated with chronic nicotine, who have unaffected
levels of nAChRs, maintain a consistent daily nicotine
dose similar to light smokers and do not exhibit tolerance.
Conversely, the forced nicotine delivery by an osmotic
pump, secreting a five-fold higher dose of nicotine com-
pared to peak self-administration doses, may yield a level
of upregulation which the mice are incapable of maintain-
ing with oral self-administration of nicotine. Still, we are
able to correlate nicotinic receptor upregulation, caused
by forced pretreatment with an osmotic pump, with an in-
crease in the magnitude of nicotine self-administration.
Another potential contributing factor to the significantly
elevated nicotine drinking behavior of the nicotine primed
mice is the issue of receptor desensitization. As proposed
by Dani and Heinemann [47] a possible explanation of in-
creased nicotine intake for smokers is that the abnormally
high synaptic activity that would be brought about by up-
regulated receptors in the non-rewarding cholinergic
synapses could contribute to withdrawal symptoms. The
consumption of nicotine would desensitize the additional
upregulated nAChRs down to normal nicotinic activity
and thus, would relieve withdrawal symptoms. The poten-
tial reason that nicotine self-administration is greatest for
the nicotine pump mice the first week following pump re-
moval and slowly declined nicotine consumption in subse-
quent weeks is due to the fact that receptor upregulation
is likely greatest at the first week following pump adminis-
tration when nicotine administration was forced at a level
five times greater than possible than possible with the self-
administered dose. Over time the receptors would come
back closer to normal or saline pump levels due to the in-
ability of oral self-administration of nicotine to out-pace
the constant high concentration of nicotine delivery via
pumps. Thus, we speculate that nicotine pretreated mice
would need to consume less nicotine over time since there
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back to their normal level of activity. Continuous chronic
delivery of nicotine has been shown to result in a peak ex-
pression of high affinity nAChRs by seven days and fall
back to baseline control levels by eight days following re-
moval of nicotine exposure [43]. This is consistent with
the time course of the oral nicotine consumption in our
study; however, the oral nicotine consumption would
maintain some degree of receptor upregulation to per-
petuate elevated oral nicotine consumption.
Conclusions
This study demonstrates that chronic pre-exposure to
nicotine at a dosing regimen that results in maximal α4*
nAChR upregulation results in significantly elevated oral
nicotine self-administration in a two-bottle choice para-
digm in mice. We also demonstrate that chronic nico-
tine pretreated mice exhibit heightened binge drinking
immediately following a period of nicotine abstinence.
To conclusively demonstrate causality that nAChR up-
regulation contributes to nicotine addiction would re-
quire further studies using molecular strategies targeting
the knock-down of α4 nAChR subunits and studying the
effect on nicotine self-administration.
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